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Regulation of Iron-Related Molecules In the Rat 
Hippocampus: Sex- and Age-Associated Differences 
Srinivasarao Thulluri1·3*, Miaozong Wu2·3A*, Eric R. Blough2·3·5, Nandini D.P.K. Manne2·3, 
Ashley B. Litchfield\ Bin Wang 1,3 
1 Department of Chemistry, 2Department of Biological Sciences, 3Center for Diagnostic Nanosystems, 
4Department oflnternal Medicine, 5Department of Pharmacology, Physiology and Toxicology, 
Marshall University, Huntington, WV 25755 
Abstract. Iron accumulation, especially that of free oxidized ferrous iron, has been shown to induce tissue 
oxidative damage and contribute to brain aging and the development of neurodegenerative disease. Here 
we examine whether sex and advanced age affect the expression of iron-related molecules that participate in 
regulating free iron levels (heme oxygenase I (HOI), iron-regulatory protein I (IRPI), and ferritin heavy 
chain (FTH)) and whether changes in the expression of these molecules are associated with differences in 
the expression of alpha-synuclein (ASN) which is thought to be a critical regulator in the pathogenesis of 
neurodegeneration. Using a well-established aging animal model, we demonstrate that the expression of 
HOI, FTH, and IRPI mRNAs is higher in the female hippocampus than that observed in male Fischer 
344/NNiaHSD x Brown Norway/BiNia (F344BN) rats, regardless of age group. Consistent with these sex-
associated alterations in iron-related regulators, the expression of ASN mRNA and protein in the female 
hippocampus was lower than that found in male rats. These results suggest a sex-dependent difference in 
regulating the expression of molecules involved in iron metabolism and neurodegeneration. A similar find-
ing in humans, if present, may help to shed light on why sex may affect the incidence of neurodegenerative 
disorders. 
Key words: Sex, Aging, Hippocampus, Heme oxygenase I (HOI), Ferritin, Iron-regulatory protein I 
(IRPI), Alpha-synuclein (ASN) 
Introduction 
It is well known that advanced age is associated 
with an elevated risk of developing Parkinson's dis-
ease and other neurodegenerative disorders [I, 2]. 
The mechanism(s) responsible for the pathological 
development of these disorders is currently unclear, 
but some have suggested that a diminished ability 
to respond to stress, elevations in tissue reactive 
oxygen species (ROS), and alterations in metal ho-
meostasis may be involved [3-7]. Indeed, age-asso-
ciated increases in tissue iron are associated with 
increased tissue ROS and neuronal damage, 
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e-mail: wangb@marshall.edu 
leading to the hypothesis that the accumulation of 
iron in the brain may play a key role in brain aging 
and in the development of age-related neurodegen-
erative disease [I, 8-10]. In addition to aging, it is 
also likely that sex plays a role, as males exhibit a 
significantly higher incidence of Parkinson's dis-
ease than females [2], although no significant dif-
ferences in iron level have been reported between 
male and female brains [II]. Information regarding 
how sex may influence the development of age-as-
sociated neurodegenerative diseases is currently 
sparse. 
Heme oxygenase (HO) is a ubiquitously expressed 
enzyme responsible for the degradation of heme 
[I2]. The expression of HOI is induced by cellular 
stress, such as that caused by exposure to UV light, 
elevated levels of pro-oxidants, or metal 
0091-7370/12/0200-145. © 2012 by the Association of Clinical Scientists, Inc. 
146 Annals of Clinical & Laboratory Science, vol. 42, no. 2, 2012 
dyshomeostasis [13, 14]. Deregulation of HOI has 
been linked to several neurodegenerative disorders, 
including Alzheimer's disease and Parkinson's dis-
ease [15-17]. When released from heme, free iron 
can be sequestered by binding with ferritin, a glob-
ular protein that contains 24 subunits composed of 
two functionally-distinct proteins that are encoded 
at various ratios by two different genes: ferritin 
heavy chain (FTH, 21 kDa) and ferritin light chain 
(FTL, 19 kDa). FTH-rich ferritin predominates in 
cells and tissues that have high oxidative respira-
tion because FTH functions to catalyze the oxida-
tion of Fe2+ [18]. These ferritin molecules not only 
function in iron storage, but also help to prevent 
increased free-iron-mediated oxidative damage. 
Although not well understood, the regulation of 
iron metabolism is, at least partially, regulated by 
the iron-regulatory proteins (IRPs) [19]. IRPl is the 
most abundant isoform that can bind to mRNAs 
bearing iron-responsive elements (IREs) and de-
crease expression of iron-related proteins such as 
FTH and FTL [19, 20]. 
Increased expression of alpha-synuclein (ASN) is 
thought to relate to the development of neurode-
generative diseases [21]. Elevated ASN mRNA and 
protein expression have been reported in Parkinson's 
patients [22-24]. The ASN molecules can aggregate 
and form abnormal protein clusters in the Lewy 
bodies, a structure commonly found in the brains 
of Parkinson's patients [22-25]. Interestingly, an 
IRE-like stem-loop structure has been found in the 
5' untranslated region (5'UTR) of ASN mRNA 
[26, 27], which suggests the possibility of a link be-
tween iron dysregulation and the development of 
neurodegenerative diseases. 
Here we hypothesize that sex and advanced age af-
fect the expression of iron-related molecules, which 
in turn alter the expression of alpha-synuclein. It 
has been suggested that the hippocampus is more 
vulnerable to oxidative damage, and that dopa-
mine denervation in Parkinson's disease is associ-
ated with ASN deposition in the hippocampus 
[28]. Therefore, we chose to examine how sex and 
advanced age affect iron-related molecules and ex-
pression of ASN in the hippocampus of Fischer 
344/NNiaHSD x Brown N orway/BiNia (F344BN) 
rats, a well-established aging animal model [29]. 
Our findings provide evidence for sex-dependent 
differences in the expression of molecules involved 
in iron metabolism and neurodegeneration in the 
rat hippocampus. 
Materials and Methods 
Animals. Animal care and use were approved by 
the Marshall University Institutional Animal Care 
and Use Committee (IACUC approval number 
#346), and the "Principles of Laboratory Animal 
Care" (NIH publications No. 86-23, revised 1985) 
were followed. Male (6- and 33-month-old) and 
female (6- and 30-month-old) F344BN rats (n = 6 
in each of the 4 groups) were obtained from the 
National Institute of Aging (Bethesda, MD). 
Animals were housed 2 per cage in a vivarium ap-
proved by the American Association of Laboratory 
Animal Care. Housing conditions included a 12-
hour light/dark cycle, with the temperature main-
tained at 22 ± 2aC as previously outlined [5]. Food 
and water were provided ad libitum, and animals 
were allowed to recover from shipment for at least 
2 weeks before experimentation. Based on rat sur-
vival curves obtained from the National Institute 
of Aging, the age of a 30-month-old female 
F344BN is approximately equivalent to that of a 
33-month-old male rat. Six-month-old male and 
female rats (n = 6 per group) were used as the adult 
controls. 
Tissue isolation. The rats were anesthetized by an 
intraperitoneal injection of a ketamine-xylazine 
(4:1) cocktail administered at 50 mg/kg, and sup-
plemented as necessary for reflexive response as de-
tailed elsewhere [5]. Brains were removed and 
rinsed in Krebs solution to remove any superficial 
blood. The hippocampus was quickly separated 
from the whole brain, blotted dry, and immediately 
frozen in liquid nitrogen [30]. Tissue samples were 
stored at -80aC until further use. 
RNA extraction and real-time quantitative 
PCR (RT-qPCR). The hippocampus tissue was ho-
mogenized in TRI reagent (Ambion, Austin, TX) 
at a ratio of 1 mL of TRI reagent per 100 mg of 
tissue, as outlined by the manufacturer. After a 5 
minute incubation, the homogenates were centri-
fuged (12,000 x g for 15 min at 4°C). The supernate 
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Inc., Foster City, CA) as pre-
Table I. PCR primers used to quantify the levels of HOI, FTH, 
IRPI, ASN, B-actin, and GAPDH transcripts 
viously outlined [31, 32]. PCR 
reactions were run on an ABI 
7000 Real-Time PCR system 
HOI forward primer 5'-TGCTCGCATGAACACTCTG-3' 
HOI reverse primer 5'-TCCTCTGTCAGCAGTGCCT-3' 
FTH forward primer 5'-CTGAATGCAATGGAGTGTGC-3' 
FTH reverse primer 5'-TCTTGCGTAAGTTGGTCACG-3' 
IRPI forward primer 5'-TTGCCGAGCCCTTGGACCCT-3' 
IRPI reverse primer 5'-TCACAGTTCCGAACGGCGGC-3' 
ASN forward primer 5'-AGGGAGTCGTTCATGGAGTG-3' 
ASN reverse primer 5'-CCCTCCACTGTCTTCTGAGC-3' 
B-actin forward primer 5'-CAACCTTCTTGCAGCTCCTC-3' 
B-actin reverse primer 5'-TCTGACCCATACCCACCATC-3' 
(Applied Biosystems Inc., 
Foster City, CA) using the 
following cycling conditions: 
50aC for 2 minutes, 95aC for 
10 minutes, followed by 40 
cycles at 95aC for 15 seconds 
and 60aC for 1 minute [31, 
32]. All experiments were re-
peated in triplicate using 
~-actin and glyceraldehyde 
3-phosphate dehydrogenase 
(GAPDH) as an internal con-
trol. The forward and reverse 
GAPDH forward primer 5'-GGCTCTCTGCTCCTCCCTGTTCT-3' 
GAPDH reverse primer 5'-GCCAAATCCGTTCACACCGACCTT-3' 
was collected and mixed with 200 f.!L chloroform 
(Sigma-Aldrich, Inc., St. Louis, MO). After a 10 
minute incubation at room temperature, the aque-
ous phase of the mixed solution was collected via 
centrifugation (12,000 x g for 15 min at 4aC) and 
then mixed with 500 f.!L isopropanol (Sigma-
Aldrich Inc., St. Louis, MO). RNA pellets were 
precipitated (12,000 x g for 10 min at 4aC), washed 
with 75% ethanol, and then dried under vacuum 
(Eppendorf Vacufuge Model 5301 Vacuum 
Concentrator, Westbury, NY). After dissolving the 
RNA pellet with 50 f.!L of nuclease-free water, 
RNA was quantified at 260 nm using a NanoVue 
UV-Vis Spectrophotometer (GE Healthcare, 
Piscataway, NJ). RNA integrity was confirmed us-
ing a RNA 6000 Nano Kit and an Agilent 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, 
CA). RNA samples were stored at -80aC until 
further use. 
Reverse transcription coupled with RT-qPCR was 
used to quantify the relative abundance of HOI, 
FTH, IRPl, and ASN mRNAs in hippocampus 
samples. Complimentary DNA (eDNA) libraries 
were synthesized using a High Capacity eDNA 
Reverse Transcription Kit (Applied Biosystems 
Inc., Foster City, CA) as per the manufacturer's in-
structions. RT-qPCR was set up using the Power 
SYBR Green PCR Master Mix (Applied Biosystems 
primers (Table 1) were pur-
chased from Integrated DNA 
technologies (San Diego, 
CA). The expression of HOI, FTH, IRPl, and 
ASN mRNAs were normalized to the geometric 
means of ~-actin and GAPDH mRNAs, and the 
2-L\.Ct method was used to calculate the relative 
mRNA expression level [31, 32]. 
Immunoblotting analysis. Hippocampus protein 
was extracted via homogenization in Pierce tissue 
protein extraction reagent buffer (T-PER; Thermo 
Fisher Scientific Inc., Rockford, IL) containing 
protease inhibitors (#P8340; Sigma-Aldrich Inc., 
St. Louis, MO) and phosphatase inhibitors 
(#P5726; Sigma-Aldrich Inc., St. Louis, MO) as 
previously detailed [5, 33]. The total protein con-
centration of each homogenate was determined us-
ing the Pierce 660 nm protein assay (Pierce, 
Rockford, IL). Samples containing equal amounts 
of protein (to a final concentration of 2.0 flglf.!L) 
were boiled in SDS-loading buffer (Sigma-Aldrich 
Inc., St. Louis, MO), and then separated on precast 
10 or 15% SDS-PAGE gels (Lonza Rockland, 
Rockland, ME) before being transferred to nitro-
cellulose membranes as described elsewhere [5, 33]. 
Gels were stained with RAPID protein reagent 
(G-Biosciences, St. Louis, MO) to confirm equal 
protein loading and the transfer efficiency of pro-
teins onto the membranes. 
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Figure I Heme oxygenase I (HOI) mRNA expression in the hippo-
campus in adult and aged female and male F344BN rats (F-6 and 
F-30: 6- and 30-month-old female rats; M-6 and M-33: 6- and 
33-month-old male rats). Data are means± SEM (n = 6 per group). 
There are gender (p ::::; 0. 05) and age (p ::::; 0. 05) differences, but there 
is no interaction between gender and age (p = 0.47). f: age difference 
(p ::::; 0.05) within the same gender; *:gender difference (p ::::; 0.05) 
within the same age. 
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Figure 2 Ferritin heavy chain (FTH) mRNA expression in the hip-
pocampus in adult and aged female and male F344BN rats (F-6 and 
F-30: 6- and 30-month-old female rats; M-6 and M-33: 6- and 
33-month-old male rats). Data are means± SEM (n = 6 per group). 
There is a difference by gender (p ::::; 0. 05), but there is neither an age 
effect (p = 0.20) nor an interaction between gender and age (p = 
0.86). *:gender difference (p::::; 0.05) within the same age. 
The expression of the target protein 
was visualized following incubation of 
the nitrocellulose membranes with 
ECL Western Blotting reagent (GE 
Healthcare Bio-Sciences, Piscataway, 
NJ). The amount of target protein 
present was quantified using 
AlphaEaseFC image analysis software, 
and was normalized to the amount of 
GAPDH. 
Data analysis. Results are presented 
as the mean ± SEM. A two-way analy-
sis of variance (ANOVA) followed by a 
Student-Newman-Keuls test was per-
formed using the SigmaStat 3.5 statis-
tical program (SPSS Science Inc., 
Chicago, IL) to determine the effect of 
sex (male versus female), age (adult 
versus aged), and the interaction of sex 
x age on both mRNA and protein ex-
pression. A value of p::::; 0.05 was con-
sidered to be statistically significant. 
Results 
The expression of HOI, FTH, and 
IRPI mRNAs in rat hippocampus. 
The expression of HOI mRNA was 
higher in the female hippocampus 
than that observed in the male ani-
mals (p::::; 0.05; Figure 1). The expres-
sion of HOI mRNA in the aged fe-
male hippocampus was higher than 
that in the adult female rats (p::::; 0.05), 
while HOI mRNA expression was 
unaltered with aging in males (Figure 
1). The expression of both FTH and 
IRPI mRNAs in the female hippo-
campus were higher than in male rats 
To probe for the antigen of interest, the nitrocellu-
lose membranes were first incubated with an anti-
gen-specific primary antibody, followed by incuba-
tion with the appropriate horseradish peroxidase 
(HRP)-linked secondary antibody. The primary 
antibody against ASN was purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA); the 
GAPDH antibody and HRP-linked anti-rabbit 
IgG secondary antibody were obtained from Cell 
Signaling Technology (Danvers, MA). 
(p::::; 0.05; Figures 2, 3), and were un-
altered with aging in rats of either sex (Figures 2, 
3). 
The expression of ASN mRNA in rat hippocam-
pus. The expression of ASN mRNA in the female 
hippocampus was lower than that observed in ei-
ther the adult or aged male rats (p::::; 0.05; Figure 4) 
and was unaltered with aging in rats of either sex 
(Figure 4). 
The expression of ASN protein in rat hippocam-
pus. The expression of ASN protein was lower in 
the female hippocampus than in that 
of males (p :c:; 0.05; Figure 5). The ex-
pression of ASN protein in the aged 
female hippocampus was higher than 
that in adult female rats (p :c:; 0.05), 
and was unaltered with aging in 
males (Figure 5). 
Discussion 
It is well known that females and 
males display different rates of aging, 
while others have postulated that the 
interaction of sex with age may play a 
role in the development of disease [2, 
34-36]. Using the F344BN rat model 
[5, 10, 29], we have herein demon-
strated significant sex-associated dif-
ferences in the regulation of iron- and 
neurodegeneration-related molecules 
in the hippocampus. These data sup-
port the possibility that sex may play 
a role in the development of age- and 
iron-related neurodegenerative 
diseases. 
HOI is an inducible heme oxygenase 
that functions to degrade the pro-
oxidant heme in response to stress. 
Consistent with previous work [37], 
we demonstrated that the expression 
ofHOI is increased with age (Figure 
1). We also found, for both adult and 
aged rats, that HOI expression is 
higher in the female hippocampus 
when compared to that observed in 
the age-matched male hippocampus 
(Figure 1). As an important antioxi-
dant enzyme and a dynamic sensor of 
cellular oxidative stress, the increased 
HOI expression in the aged female 
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Figure 3 Iron-regulatory protein (IRPI) mRNA expression in 
the hippocampus in adult and aged female and male F344BN 
rats (F-6 and F-30: 6- and 30-month-old female rats; M-6 
and M-33: 6- and 33-month-old male rats) Data are means± 
SEM (n = 6 per group). 1here is a gender effect (p :c:;0.05), but 
there is neither an age (p = 0.56) nor an interaction between 
gender and age (p = 0. 86). *:gender difference (p :c:; 0. 05) with-
in the same age. 
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Figure 4 Alpha-synuclein (ASN) mRNA expression in the hip-
pocampus in adult and aged female and male F344BN rats 
(F-6 and F-30: 6- and 30-month-old female rats; M-6 and 
M-33: 6- and 33-month-old male rats) Data are means ± 
SEM (n = 6 per group). 1here is a difference by gender (p :c:; 
0.05), but there is neither an age effect (p = 0.31) nor an inter-
action between gender and age (p = 0.49). *:gender difference 
(p :c:; 0.05) within the same age. 
hippocampus may protect cells by degrading pro-
oxidant metalloporphyrins. This finding, if pres-
ent, may help to explain why some have suggested 
that the female rat brain exhibits better control of 
oxidative stress balance than does the male brain in 
animals of similar ages [11, 38]. 
oxidative stress, as it mediates the formation of free 
radicals [39, 40]. Although no significant differ-
ences in total iron level between male and female 
brains of Sprague-Dawley rats have been reported 
[11], it is worthwhile to note that it is free ferrous 
iron that mediates the formation of free radicals 
[39, 40]. When bound to the iron storage protein 
ferritin, free ferrous iron is converted to a non-toxic 
form [I8, 4I]. Given that the expression ofFTH is 
Free ferrous iron generated from the HOI-induced 
degradation of heme is a potential stimulator of 
I50 Annals of Clinical & Laboratory Science, vol. 42, no. 2, 2012 
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functions to inhibit the binding of 
IRPI to IRE thereby allowing trans-
ASN lation and synthesis of proteins [I8, 26]. Additional data from in vitro ex-
periments has suggested that knock-
down of IRPI results in increased ex-
pression of both ASN mRNA and 
protein in human SK-N-SH cells 
[42]. In the current study, we ob-
served higher expression of HOI 
(Figure 1) and FTH (Figure 2) in 
the female hippocampus, which is 
consistent with the possibility of di-
minished free iron content. This find-
ing, if present, suggests a higher bind-
ing ofiRPI to the IRE in the 5'UTR 
of target mRNA and inhibition of 
target protein translation [I8, 26]. 
This possibility is supported by our 
findings of decreased ASN mRNA 
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Figure 5. Alpha-synuclein (ASN) protein expression in the hippocam-
pus in adult and aged female and male F344BN rats (F-6 and F-30: 
6- and 30-month-old female rats; M- 6 and M-33: 6- and 33-month-
old male rats). Data are means± SEM (n = 6 per group). 1here are 
gender (p :c:; 0.05) and age (p :c:; 0.05) differences. f: age difference (p :c:; 
0.05) within the same gender; *:gender difference (p :c:; 0.05) within 
the same age. 
pus (Figures 4 and 5, respectively). 
Although the results of the present 
study alone are not sufficient to deter-
mine whether there is a causative link 
between the development of neurode-
generative diseases, ASN expression, 
higher in the female hippocampus than in that of 
age-matched males (Figure 2), it is possible that 
the female brain is better able to "capture" free iron 
from tissues, thus potentially protecting against its 
deleterious effects and the associated oxidative 
damage. Future research that includes the mea-
surement of free ferrous iron in hippocampal tissue 
will provide valuable information for testing this 
hypothesis. 
It has been shown that iron can induce the misfold-
ing and aggregation of ASN protein to form the 
main component of the intracytoplasmic Lewy 
bodies, an abnormal protein cluster found in the 
brains of Parkinson's patients [22-25]. Interestingly 
an IRE-like stem-loop structure has recently been 
found in the 5'UTR of ASN mRNA [26]. Studies 
have shown that when intracellular free iron con-
tent is low, IRPI binds to the IRE in the 5'UTR of 
mRNA and inhibits its translation. Conversely, in-
creased intracellular free 1ron concentration 
and iron dysregulation, they may pro-
vide insight into the mechanism(s) potentially re-
sponsible for the significantly higher incidence of 
Parkinson's disease in men than in women [2]. 
Further study using pharmacological intervention 
and/or transgenic animals will no doubt shed light 
on the definitive mechanism. 
In summary, this study demonstrates sex- and age-
dependent differences in the expression of iron-re-
lated molecules (HOI, FTH, and IRPI) in the hip-
pocampus of F344BN rats. These differences are 
linked to differences in the expression of ASN, a 
critical protein related to the development of neu-
rodegenerative diseases. These data provide the mo-
lecular basis for further study to address the effects 
of sex, iron accumulation, and advanced age on the 
pathological development of neurodegenerative 
diseases. 
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